Genetic Counseling
Methodology & AI Transparency ⓘ
Genetic Counseling Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Genetic counseling provides information and support to people who have, or may be at risk for, genetic disorders .
- 2 Real-world patient consensus: Federal ICD-10-CM code O00.2 categorizes Genetic Counseling under Fertility, Pregnancy & Postpartum Care.
- 3 Typical cash cost range: Differential triage of Genetic Counseling (O00.2) utilizes gestational glycemic [Genetic Counseling O00.2].
- 4 Top reported side effects / signs: Longitudinal Genetic Counseling monitoring tracks Maternal Blood Pressure in Genetic Counseling (O00.2: & Urine Protein) toward BP < 120/80 mmHg; negative proteinuria (O00.2).
Ask our AI Specialists anything about Genetic Counseling
What Is Genetic Counseling?
Genetic counseling provides information and support to people who have, or may be at risk for, genetic disorders . A genetic counselor meets with you to discuss genetic risks. The counseling may be for yourself or a family member. Or you may get it when you are planning or expecting a baby. You may follow up with genetic testing . There are many reasons to seek genetic counseling.
Pathophysiology, Underlying Causes & Clinical Presentation
In Genetic Counseling (O00.2), physiological disruption stems from ovulatory hypothalamic-pituitary-gonadal axis in Genetic Counseling (O00.2: disruption), Cross-referenced with NIH MeSH (Genetic Counseling), informing Fertility, Pregnancy & Postpartum Care protocols that track Prenatal TSH, Ferritin in Genetic Counseling (O00.2: & Glucose Screen) (Trimester-specific clinical range (O00.2)).
Common Symptoms & Clinical Signs
- • Have a personal or family history of a genetic condition or birth defect
- • Are pregnant or planning to be pregnant after age 35
- • Presentation of Genetic Counseling (O00.2): inability to achieve in Genetic Counseling (O00.2: clinical pregnancy after)
- • Secondary Genetic Counseling clinical sign: irregular luteal phase in Genetic Counseling (O00.2: timing, anovulatory cycles,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Genetic Counseling Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | O00.2 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Fertility, Pregnancy & Postpartum Care | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Maternal Blood Pressure in Genetic Counseling (O00.2: & Urine Protein) | BP < 120/80 mmHg; negative proteinuria (O00.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Prenatal TSH, Ferritin in Genetic Counseling (O00.2: & Glucose Screen) | Trimester-specific clinical range (O00.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Anti-Mullerian Hormone (AMH) in Genetic Counseling (O00.2: & Day-3 FSH) | Age-contextual ovarian reserve (O00.2) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Genetic Counseling
Treatment selection for Genetic Counseling depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Genetic Counseling)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Efficacy comparison of monotherapies and combination therapies for androgenetic: What a 3,133-Participant Study Found In recent years, combination therapies are showing significant promise as potential therapies. Dermatologic therapy • 2022-03-15 • Meta-Analysis | N = 3,133 | 99/100 | PMID 34897933 ↗ |
| New Insights on Combination Therapy in Androgenetic hair loss: A Network Meta-Analysis of: What a 3,012-Participant Study Found Based on the current studies, we found that the combination of Minoxidil with spironolactone, PRPF, flutamide, and finasteride may offer better treatment outcomes for patients with androgenetic hair loss. Aesthetic plastic surgery • 2026-07-15 • Meta-Analysis | N = 3,012 | 99/100 | PMID 42168420 ↗ |
| New Insights on Glycolipid and Hormonal Profiles in Young Men with Early-Onset Androgenetic hair: What a 1,009-Participant Study Found The acknowledgement of this syndrome would be of importance to prevent the long-term consequences on health in the affected men. Scientific reports • 2017-08-10 • Meta-Analysis | N = 1,009 | 94/100 | PMID 28798373 ↗ |
| New Insights on Clinical trial of 5% skin-applied minoxidil versus 2% skin-applied minoxidil and: What a 393-Participant Study Found In men with AGA, 5% applied to the skin minoxidil was clearly superior to 2% applied to the skin minoxidil and placebo in increasing hair regrowth, and the magnitude of its effect was marked (45% more hair regrowth than 2%... Journal of the American Academy of Dermatology • 2002-09-15 • Randomized Controlled Trial | N = 393 | 93/100 | PMID 12196747 ↗ |
| New Insights on Benefits and safety of skin-applied finasteride spray solution in the treatment: What a 270-Participant Study Found In Chinese men with AGA, applied to the skin finasteride spray solution increased hair growth and showed good safety and tolerability profile during a 24-week treatment period. Chinese medical journal • 2026-04-05 • Phase III Randomized Trial | N = 270 | 93/100 | PMID 40090937 ↗ |
Genetic Counseling Patient Community & “People Like Me” Threads
Filter Genetic Counseling community threads and patient logs by age, biological sex, dosage, and treatment duration.